At least 21 Indian companies with a market cap of over INR 5bn ($66m) saw their profits decline in each of the past four quarters and their...

Independent analyst Manish Shah said if Nifty50 manages to close above the 15,930-15,950 range for the next two-three consecutive sessions,...

The drug firm's consolidated net profit came in at Rs 26.76 crore for the quarter ended March 31.

Nifty futures on the Singapore Exchange traded 12 points, or 0.08 per cent, lower at 14,670.50 in signs that Dalal Street was headed for a ...

"We might see further consolidation after the recent up move. However, the bias would remain on the positive side," said Ajit Mishra, VP - ...

Confirmed Covid-19 cases in India rose above 18 million with a record rise in infections and deaths over the last 24 hours.

Its consolidated total revenue stood at Rs 208.38 crore for the quarter under consideration.

Company as well as sector-specific developments mainly drove a couple of stocks.

A second stimulus package India is poised to announce in coming days will be worth around Rs 1 lakh crore.

As many as 209 stocks, including Indiabulls Integrated and Ruchi Soya hit their lower circuits on BSE.

Brokerages turned cautious on the sector just ahead of September quarter earnings.

Nifty Pharma index outpaced the benchmark index which slipped more than 1 per cent.

Here's a look at the top stocks that are likely to hog limelight in today's trading session.

Let's check out what all might matter to Dalal Street on Tuesday.